The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kymera Therapeutics, Inc(NASDAQ:KYMR) 
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase...
Website: http://www.kymeratx.com
Founded: 2016
Full Time Employees: 64
CEO: Nello Mainolfi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Kymera Therapeutics Days Payable Outstanding ttm (DPO)
Kymera Therapeutics Days Receivable Outstanding ttm (DSO)
Kymera Therapeutics Op Cashflow Per Share ttm
Kymera Therapeutics Free Cashflow Per Share ttm
Kymera Therapeutics Cash Per Share ttm
Kymera Therapeutics P/S ratio ttm
Kymera Therapeutics (GAAP) P/E ratio ttm
Kymera Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.